(Q31135042)

English

Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1 reference

Europe PubMed Central

Quantification of antiretroviral drugs for HIV-1 in the male genital tract: current data, limitations and implications for laboratory analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

author name string

Derek J Chan

1

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

John E Ray

2

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

1451-1462

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

International interlaboratory quality control program for measurement of antiretroviral drugs in plasma

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Persistence of primary drug resistance among recently HIV-1 infected adults

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Evaluation of antiretroviral drug measurements by an interlaboratory quality control program

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Biological correlates of HIV-1 heterosexual transmission

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Time trends in primary HIV-1 drug resistance among recently infected persons

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Human immunodeficiency virus in semen and plasma: investigation of sexual transmission risk behavioral correlates

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Modelling the effect of combination antiretroviral treatments on HIV incidence.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

The prostate of the nonhuman primate: Normal anatomy and pathology

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Is the male genital tract really a sanctuary site for HIV? Arguments that it is not.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Use of PCR to measure HIV viral changes in drug-resistant genes in genital fluids.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Limited penetration of lopinavir into seminal plasma of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of HIV-1 protease inhibitors into CSF and semen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Antiretroviral drug concentrations in semen of HIV-1 infected men

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of atazanavir in seminal plasma of men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Penetration of the nucleoside analogue abacavir into the genital tract of men infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Effect of antiviral treatment on the shedding of HIV-1 in semen

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Passage of chemicals into human and animal semen: mechanisms and significance

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Poor penetration of the male genital tract by HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.11.0001

21 January 2018

Identifiers

10.1211/JPP.59.11.0001

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31135042&oldid=1606405075"